This is a preview of subscription content, log in via an institution to check access.
References
Reiter RJ, Tan DX, Qi W, et al. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept 2000; 9: 160-171.
Bertuglia S, Marchiafava PL, Colantuoni A. Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 1996; 31: 947-952.
Konturek PC, Konturek SJ, Majka J, et al. Melatonin affords protection against gastric lesions induced by ischemiareperfusion possibly due to its antioxidant and mucosal microcirculatory effects. Eur J Pharmacol 1997; 322: 73-77.
Whittle BJ, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99: 607-611.
Borlongan CV, Yamamoto M, Takei N, et al. Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. Faseb J 2000; 14: 1307-1317.
Ustundag B, Kazez A, Demirbag M, et al. Protective effect of melatonin on antioxidative system in experimental ischemiareperfusion of rat small intestine. Cell Physiol Biochem 2000; 10: 229-236.
Blatt CM, Rabinowitz SH, Lown B. Central serotonergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardium. Circ Res 1979; 44: 723-730.
Verrier RL. Neurochemical approaches to the prevention of ventricular fibrillation. Fed Proc 1986; 45: 2191-2196.
Tan DX, Manchester LC, Reiter RJ, et al. Ischemia/ reperfusion-induced arrhythmias in the isolated rat heart: Prevention by melatonin. J Pineal Res 1998; 25: 184-191.
Kaneko S, Okumura K, Numaguchi Y, et al. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci 2000; 67: 4101-112.
Lagneux C, Joyeux M, Demenge P, et al. Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci 2000; 66: 503-509.
Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: An overview. Cardiovasc Drugs Ther 1991; 5(Suppl 2): 249-268.
Dave RH, Hale SL, Kloner RA. The effect of melatonin on hemodynamics, blood flow, and myocardial infarct size in a rabbit model of ischemia-reperfusion. J Cardiovasc Pharmacol Ther 1998; 3: 153-160.
Salie R, Harper I, Cillie C, et al. Melatonin protects against ischaemic-reperfusion myocardial damage. J Mol Cell Cardiol 2001; 33: 343-357.
Szarszoi O, Asemu G, Vanecek J, et al. Effects of melatonin on injury produced by ischemia and reperfusion injury of the rat heart. Cardiovasc Drugs Ther 2001; 15: 251-258.
Girotti L, Lago M, Ianovsky O, et al. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease. J Pineal Res 2000; 29: 138-142.
Vanden Hoek TL, Becker LB, Shao Z, et al. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998; 273: 18092-18098.
Pain T, Yang XM, Critz SD, et al. Opening of mitochondrial K+ATP channels triggers the preconditioned state by generating free radicals. Circ Res 2000; 87: 460-466.
Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redoxsensitive mechanism. Circ Res 2001 88: 802-809.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Duncker, D., Verdouw, P. Has Melatonin a Future as a Cardioprotective Agent?. Cardiovasc Drugs Ther 15, 205–207 (2001). https://doi.org/10.1023/A:1011903904056
Issue Date:
DOI: https://doi.org/10.1023/A:1011903904056